ISAACSON, B. - BULLOVÁ, Petra - FRONE, M. - CLICK, A. - HAMPLOVA, B. - RABAGLIA, J. - WOODRUFF, S. - NWARIAKU, F. - KATHURIA, A. - PACÁK, Karel - GHAYEE, H.K. An aggressive temporal bone SDHC paraganglioma associated with increased HIF-2 alpha signaling. In Endocrine practice, 2016, vol. 22, no. 2, p. 190-195. (2016 - Current Contents). ISSN 1530-891X. Available on: https://doi.org/10.4158/EP15889.OR
:Ohlasy:
:[1.1] BOURDEAU, Isabelle - GRUNENWALD, Solange - BURNICHON, Nelly - KHALIFA, Emmanuel - DUMAS, Nadine - BINET, Marie-Claire - NOLET, Serge - GIMENEZ-ROQUEPLO, Anne-Paule. A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL. In JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. ISSN 0021-972X, 2016, vol. 101, no. 12, pp. 4710-4718., Registrované v: WOS
:[1.1] ONG, Raquel Kristin S. - FLORES, Shahida K. - REDDICK, Robert L. - DAHIA, Patricia L. M. - SHAWA, Hassan. A Unique Case of Metastatic, Functional, Hereditary Paraganglioma Associated With an SDHC Germline Mutation. In JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. ISSN 0021-972X, 2018, vol. 103, no. 8, pp. 2802-2806., Registrované v: WOS
:[1.1] MURUGESAN, Thanabal - RAJAJEYABALACHANDRAN, Gurukumari - KUMAR, Swetha - NAGARAJU, Shruthi - JEGATHEESAN, Sooriya Kumar. Targeting HIF-2 as therapy for advanced cancers. In DRUG DISCOVERY TODAY. ISSN 1359-6446, 2018, vol. 23, no. 7, pp. 1444-1451., Registrované v: WOS
:[1.1] HUSSEIN, Z. - KORBONITS, M. - BALDEWEG, S.E. - CHUNG, T.T. Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma. In ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS. JUN 9 2021. Dostupné na: https://doi.org/10.1530/EDM-21-0003., Registrované v: WOS